(1R,4R)-1,2,3,4-Tetrahydro-4,6-dihydroxy-1-(3-hydroxyphenyl)-2-methylisoquinoline
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

2575516-76-4(1R,4R)-1,2,3,4-Tetrahydro-4,6-dihydroxy-1-(3-hydroxyphenyl)-2-methylisoquinoline

● In Stock

Catalogue No.:VE0022905
CAS No.:2575516-76-4
Mol. Formula:C16H17NO3
Mol. Weight:271.31 g/mol

Additional information on CAS 2575516-76-4

Parent drug

Phenylephrine

IUPAC Name

(1R, 4R)-1, 2, 3, 4-Tetrahydro-4, 6-dihydroxy-1-(3-hydroxyphenyl)-2-methylisoquinoline

Pharmacopoeial Synonyms

N/A

Other Synonyms

N/A

Smiles

CN1[C@H](C2=CC=CC(O)=C2)C3=C(C=C(O)C=C3)[C@@H](O)C1

InChI

InChI=1S/C16H17NO3/c1-17-9-15(20)14-8-12(19)5-6-13(14)16(17)10-3-2-4-11(18)7-10/h2-8, 15-16, 18-20H, 9H2, 1H3/t15-, 16+/m0/s1

Description

The compound N-Methyl-3-phenyl-3-(2-(trifluoromethyl)phenoxy)propan-1-amine Hydrochloride is a thoroughly characterized reference standard that complies with rigorous regulatory guidelines | including those from USP | EMA | JP | and BP. It is ideal for critical applications such as analytical method development | method validation (AMV) | and quality control (QC) | especially in the production of Fluoxetine. Designed to support both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA) | this product delivers the precision required for reliable results. Additionally | it includes a detailed Structure Elucidation Report (SER) | ensuring accuracy and dependability for advanced analytical purposes.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url